TSX Trading Suspended - Antibe Therapeutics Inc. (ATE)

April 9, 2024
Issuer: Antibe Therapeutics Inc.
Security: Common Shares (the "Shares")
Symbol(s): ATE
Delisting Review Type: Expedited
Reason: TSX is reviewing the Shares with respect to meeting the requirements for continued listing pursuant to the Expedited Review Process.
Trading: The Shares are suspended from trading immediately.
TSX contact: Selma Thaver,
Managing Director,
TSX Listings